Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Leukemia Clinical Trials
Leukemia clinical trials are recruiting across 242 cities. Here are the cities with the most active studies:
Leukemia Trial Phases
68 research organizations are sponsoring leukemia trials.
About Leukemia
Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.
Clinical trials are advancing new treatments for leukemia. Currently, 100 studies are recruiting a combined 405,244 participants across the United States. Research is being conducted by 68 organizations including University of Utah, University of Wisconsin, Madison, University of Colorado, Denver and 65 others.
2026 Leukemia Research Landscape
As of July 2026, the leukemia clinical trial landscape includes 100 actively recruiting studies across 242 cities in the United States. These studies are collectively seeking 405,244 participants, with an average enrollment target of 4,052 per study.
The research spans multiple phases of development: 32 studies are in PHASE3, 11 studies are in NA, 10 studies are in PHASE1, 9 studies are in PHASE2, 3 studies are in PHASE4. The presence of Phase 3 trials indicates that some leukemia treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 68 different organizations, including University of Utah, University of Wisconsin, Madison, University of Colorado, Denver, Children's National Research Institute, National Institute of Allergy and Infectious Diseases (NIAID), and 63 others. The large number of sponsors reflects significant research interest and investment in leukemia treatment advancement.
Geographically, leukemia trials are most concentrated in Birmingham, Alabama (15 trials); Los Angeles, California (13 trials); Phoenix, Arizona (11 trials); Tucson, Arizona (11 trials); Baltimore, Maryland (11 trials) and 7 other cities.
Featured Leukemia Studies
Highlighted recruiting studies for leukemia, selected by enrollment size and research scope.
Machine Learning Approaches to Personalized Therapy for Advanced Non-small Cell Lung Cancer With Real-World Data
This research will leverage machine learning (ML) and causal inference techniques applied to real-world data (RWD) to generate evidence that personalizes treatment strategies for patients with advanced non-small cell lung cancer (aNSCLC). Rather than influencing regulatory decisions or clinical guidelines, the goal of this trial is to refine treatment selection among existing therapeutic options, ...
Evaluation of Pediatric eCART Implementation
This is a study comparing 3 years of retrospective data (pre-implementation) to 2 years of prospective data after the implementation of a pediatric version of Electronic Cardiac Arrest Risk Triage (pediatric eCART), a clinical decision support (CDS) tool that uses electronic health records (EHR) to identify patients with high risk for life threatening outcomes. Up to 30,000 encounters with pediatr...
Effectiveness of an Automated Falls-Risk Screening and Referral Tool in the Emergency Department (ED)
The purpose of this retrospective cohort study is to evaluate the effectiveness of an EHR-based clinical decision support system (CDS) for automatically screening older adult ED patients for risk of future falls and providing ED clinicians opportunity to place referrals orders to the UW Health Mobility and Falls Clinic for those at highest risk prior to discharge. This CDS tool has already been i...
Frequently Asked Questions About Leukemia Clinical Trials
Are there leukemia clinical trials near me?
Yes, there are 100 leukemia clinical trials currently recruiting across 242+ cities in the United States, including Birmingham, Alabama; Los Angeles, California; Phoenix, Arizona. Browse the studies above to find one at a location convenient for you.
How do I join a leukemia clinical trial?
To join a leukemia clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are leukemia clinical trials free?
Yes, participation in leukemia clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of leukemia treatments are being studied?
Current leukemia clinical trials are testing a range of approaches across PHASE3 (32 studies), NA (11 studies), PHASE1 (10 studies), PHASE2 (9 studies), PHASE4 (3 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 68 research organizations.
Is it safe to participate in leukemia clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 20, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 20, 2026 · Data from ClinicalTrials.gov